Regenxbio(RGNX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

RGNX Regenxbio

Not Yet Opened 10-21 16:00:00 EDT

7.17

-0.23

-3.11%

盘后7.17

+0.000.00%

19:30 EDT

High7.47	Low7.15	Vol945.33K
Open7.42	D1 Closing7.40	Amplitude4.32%
Mkt Cap473.31M	Tradable Cap411.15M	Total Shares66.01M
T/O6.85M	T/O Rate1.65%	Tradable Shares57.34M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"RGNX","market":"US","secType":"STK","nameCN":"Regenxbio","latestPrice":7.17,"timestamp":1792612800000,"preClose":7.4,"halted":0,"volume":945330,"hourTrading":{"tag":"盘后","latestPrice":7.17,"preClose":7.17,"latestTime":"19:30 EDT","volume":21537,"amount":154367.63,"timestamp":1792625405156,"change":0,"changeRate":0,"amplitude":0.012552},"delay":0,"changeRate":-0.03108108108108114,"floatShares":57342700,"shares":66013200,"eps":-3.765189,"marketStatus":"Not Yet Opened","change":-0.23,"latestTime":"10-21 16:00:00 EDT","open":7.42,"high":7.47,"low":7.15,"amount":6845175.746388,"amplitude":0.043243,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.765189,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1792656000000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1442462400000,"exchange":"NASDAQ","adjPreClose":7.4,"preHourTrading":{"tag":"盘前","latestPrice":7.42,"preClose":7.4,"latestTime":"09:29 EDT","volume":2662,"amount":19934.6271124,"timestamp":1792589399999,"change":0.02,"changeRate":0.002703,"amplitude":0.02973},"postHourTrading":{"tag":"盘后","latestPrice":7.17,"preClose":7.17,"latestTime":"19:30 EDT","volume":21537,"amount":154367.63,"timestamp":1792625405156,"change":0,"changeRate":0,"amplitude":0.012552},"volumeRatio":0.714034,"impliedVol":2.2762,"impliedVolPercentile":0.9562},"requestUrl":"/m/hq/s/RGNX","defaultTab":"news","newsList":[{"id":"2677870605","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: vTv Therapeutics (VTVT) and RegenXBio (RGNX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2677870605","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677870605?lang=en_us&edition=fundamental","pubTime":"2026-10-22 00:20","pubTimestamp":1792599613,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on vTv Therapeutics (VTVT) and RegenXBio (RGNX). vTv Therapeutics (V...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-vtv-therapeutics-vtvt-and-regenxbio-rgnx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-vtv-therapeutics-vtvt-and-regenxbio-rgnx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BK4137","XBI","BK4585","BK4139","RGNX","LU0029874061.USD","XLV","BK4588","LABU","VTVT","HCSG","BK4505","BK4563","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677067625","title":"Stifel Nicolaus Remains a Buy on RegenXBio (RGNX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2677067625","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677067625?lang=en_us&edition=fundamental","pubTime":"2026-10-21 19:59","pubTimestamp":1792583964,"startTime":"0","endTime":"0","summary":"In a report released today, Annabel Samimy from Stifel Nicolaus maintained a Buy rating on RegenXBio, with a price target of $42.00. According to T...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-remains-a-buy-on-regenxbio-rgnx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-remains-a-buy-on-regenxbio-rgnx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RGNX","BK4505","BK4563","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124625844","title":"Morgan Stanley Initiates Eight Biotech Names, Rating Seven Overweight","url":"https://stock-news.laohu8.com/highlight/detail?id=1124625844","media":"Analyst Calls","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124625844?lang=en_us&edition=fundamental","pubTime":"2026-10-20 10:11","pubTimestamp":1792462284,"startTime":"0","endTime":"0","summary":"","market":"fut","thumbnail":"https://static.tigerbbs.com/96e20408c3934de428b82e38a778cc26","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/96e20408c3934de428b82e38a778cc26"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Morgan Stanley Initiates Eight Biotech Names, Rating Seven Overweight","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMPS","PTCT","RGNX","TRVI","AVLN","BLTE"],"isVideo":true,"video":{"duration":320,"video_url":"https://news-video-sg.skytigris.cn/videos/remotion/3928/render_3928_1792461663591.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3928.webp","audio_url":"https://news-video-sg.skytigris.cn/videos/remotion/3928/tts/voiceover_2510d0822d39909bff1e8933.mp3","isAI":true},"gpt_icon":0},{"id":"2675599860","title":"Regenxbio - Appoints George Migausky as Chairman of the Board - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2675599860","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675599860?lang=en_us&edition=fundamental","pubTime":"2026-10-16 19:04","pubTimestamp":1792148655,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261016:nFWN461229:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RGNX","BK4139","BK4505","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675596705","title":"Regenxbio Names George Migausky Board Chairman","url":"https://stock-news.laohu8.com/highlight/detail?id=2675596705","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675596705?lang=en_us&edition=fundamental","pubTime":"2026-10-16 19:01","pubTimestamp":1792148510,"startTime":"0","endTime":"0","summary":"Regenxbio Names George Migausky Board ChairmanRegenxbio director Kenneth T. Mills resigned on October 14, 2026, effective October 21, 2026.The board appointed independent director George Migausky as c","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261016:nNDL9N8q5h:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RGNX","BK4139","BK4505","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674087468","title":"Regenxbio to Host Investor Event on Sura-Vec Wet AMD Program Ahead of Pivotal Data Readout","url":"https://stock-news.laohu8.com/highlight/detail?id=2674087468","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674087468?lang=en_us&edition=fundamental","pubTime":"2026-10-12 19:05","pubTimestamp":1791803124,"startTime":"0","endTime":"0","summary":"Regenxbio to host investor event on sura-vec wet AMD program ahead of pivotal data readoutRegenxbio will host an investor event on Oct. 20, 2026 at 1:00 p.m. ET in New York, with a webcast option.The ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261012:nNDL3FYyYn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PPH","RGNX","TRUH","LU1291159041.SGD","LU0795875086.SGD","LU1983299246.USD","LU0456855351.SGD","LU0965509010.AUD","LU1003077747.HKD","LU2112291526.USD","MEDX","LU0114720955.EUR","IE00BFTCPJ56.SGD","IXJ","VHT","LU1023059063.AUD","LU0310800379.SGD","IE000BZT7R73.USD","RXL","IE00BVYPNW00.USD","LU2129689514.USD","FTXH","ABBV","LU1496350171.SGD","LU2087621335.USD","LU0820561909.HKD","JDOC","LU0310799852.SGD","LU1548497426.USD","BK4581","BK4563","GLAM","LU1093756168.USD","XLV","IYH","PJP","LU2133065610.SGD","LU1732800096.USD","LU0859254822.USD","LU0949170772.SGD","AGNG","LU1670628061.USD","LU2237443465.HKD","IE00B19Z3581.USD","IE00BBT3K403.USD","LU2347655156.SGD","LU1839511570.USD","SG9999001440.SGD","LU0965508806.USD","FHLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673709625","title":"Mizuho Initiates REGENXBIO at Outperform With $22 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2673709625","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673709625?lang=en_us&edition=fundamental","pubTime":"2026-10-05 18:02","pubTimestamp":1791194538,"startTime":"0","endTime":"0","summary":"REGENXBIO (RGNX) has an average rating of overweight and mean price target of $22.08, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ba","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RGNX","BK4139","BK4505","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670239323","title":"Analysts Are Bullish on Top Healthcare Stocks: RegenXBio (RGNX), Benitec Biopharma (BNTC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2670239323","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670239323?lang=en_us&edition=fundamental","pubTime":"2026-09-28 18:30","pubTimestamp":1790591429,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on RegenXBio (RGNX), Benitec Biopharma (BNTC) and Vaxcy...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-regenxbio-rgnx-benitec-biopharma-bntc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-regenxbio-rgnx-benitec-biopharma-bntc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","BNTC","BK4581","XBI","LU0128526141.USD","BK4139","LU0029874061.USD","BK4585","RGNX","BK4505","BK4563","HCSG","XLV","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670476954","title":"Analysts Offer Insights on Healthcare Companies: RegenXBio (RGNX) and Resmed (RMD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2670476954","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670476954?lang=en_us&edition=fundamental","pubTime":"2026-09-25 19:40","pubTimestamp":1790336408,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on RegenXBio (RGNX) and Resmed (RMD). RegenXBio (RGNX...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-regenxbio-rgnx-and-resmed-rmd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-regenxbio-rgnx-and-resmed-rmd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4567","BK4548","LU2008162690.USD","BK4139","BK4504","LU0029874061.USD","RGNX","HCSG","RMD","BK4585","BK4505","LGHT","BK4588","XBI","LU0170899867.USD","XLV","BK4082","BK4137","LU2177674079.SGD","BK4581","BK4563","LU0128526141.USD","IE00B5TLWC47.USD","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670411947","title":"Regenxbio presents positive 3-year durability data for Surabgene Lomparvove","url":"https://stock-news.laohu8.com/highlight/detail?id=2670411947","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670411947?lang=en_us&edition=fundamental","pubTime":"2026-09-25 08:55","pubTimestamp":1790297707,"startTime":"0","endTime":"0","summary":"REGENXBIO (RGNX) “announced positive long-term follow-up data from the Phase II ALTITUDE(R) study of investigational surabgene lomparvovec (sura-ve...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/regenxbio-presents-positive-3-year-durability-data-for-surabgene-lomparvove-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/regenxbio-presents-positive-3-year-durability-data-for-surabgene-lomparvove-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["R","BK4022","BK4139","BK4563","BK4505","RGNX","BK4232"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670508416","title":"Regenxbio Reports 3-Year Durability Data for Sura-Vec in Phase II Altitude Diabetic Retinopathy Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2670508416","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670508416?lang=en_us&edition=fundamental","pubTime":"2026-09-25 07:18","pubTimestamp":1790291933,"startTime":"0","endTime":"0","summary":"Regenxbio reports 3-year durability data for sura-vec in Phase II ALTITUDE diabetic retinopathy trialRegenxbio disclosed three-year follow-up results from its Phase II ALTITUDE study of sura-vec in no","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nNDL39pZ7n:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4563","BK4139","RGNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669172439","title":"Regenxbio Says Sarepta to Pay $39 Million to Regenxbio Within 10 Days of Effective Date","url":"https://stock-news.laohu8.com/highlight/detail?id=2669172439","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669172439?lang=en_us&edition=fundamental","pubTime":"2026-09-24 05:19","pubTimestamp":1790198392,"startTime":"0","endTime":"0","summary":"Sept 24 (Reuters) - REGENXBIO Inc.::*REGENXBIO - SAREPTA TO PAY $39 MILLION TO REGENXBIO WITHIN 10 DAYS OF EFFECTIVE DATE - SEC FILING*REGENXBIO - ALL ONGOING PATENT LITIGATION REGARDING PATENTS-IN-SU","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nRSD3f6cq7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4563","BK4505","RGNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669436805","title":"Regenxbio - Sarepta to Pay $39 Mln to Regenxbio Within 10 Days of Effective Date - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2669436805","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669436805?lang=en_us&edition=fundamental","pubTime":"2026-09-24 04:06","pubTimestamp":1790194004,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nFWN45F0YD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","RGNX","BK4563","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669436801","title":"Regenxbio - All Ongoing Patent Litigation Regarding Patents-in-Suit to be Terminated with Prejudice - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2669436801","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669436801?lang=en_us&edition=fundamental","pubTime":"2026-09-24 04:06","pubTimestamp":1790194004,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nFWN45F0YD:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4505","BK4139","BK4563","RGNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669354436","title":"Regenxbio - Agrees not to Sue Sarepta or Affiliates over Existing Elevidys or Aavrh74-Based Capsids - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2669354436","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669354436?lang=en_us&edition=fundamental","pubTime":"2026-09-24 04:06","pubTimestamp":1790194004,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nFWN45F0YD:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4505","RGNX","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669310436","title":"Regenxbio Inc: Co and Trustees of University of Pennsylvania Entered into Settlement Agreement with Sarepta Therapeutics Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2669310436","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669310436?lang=en_us&edition=fundamental","pubTime":"2026-09-24 04:06","pubTimestamp":1790194004,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nFWN45F0YD:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RGNX","BK4563","BK4139","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669643638","title":"Regenxbio Settles Sarepta Patent Litigation over Elevidys for USD 39 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2669643638","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669643638?lang=en_us&edition=fundamental","pubTime":"2026-09-24 04:06","pubTimestamp":1790193996,"startTime":"0","endTime":"0","summary":"Regenxbio settles Sarepta patent litigation over Elevidys for USD 39 millionRegenxbio settled patent infringement litigation over Sarepta’s SRP-9001, marketed in the US as Elevidys, tied to two AAVrh7","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nNDL6tj1Lx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4563","RGNX","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669163379","title":"Bank of America Securities Keeps Their Buy Rating on RegenXBio (RGNX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669163379","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669163379?lang=en_us&edition=fundamental","pubTime":"2026-09-21 19:55","pubTimestamp":1789991736,"startTime":"0","endTime":"0","summary":"In a report released today, Alec Stranahan from Bank of America Securities reiterated a Buy rating on RegenXBio, with a price target of $15.00. Str...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bank-of-america-securities-keeps-their-buy-rating-on-regenxbio-rgnx-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bank-of-america-securities-keeps-their-buy-rating-on-regenxbio-rgnx-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PGF","BAC","RGNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665322483","title":"Regenxbio to Join Baird, Morgan Stanley Healthcare Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2665322483","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665322483?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:06","pubTimestamp":1788865570,"startTime":"0","endTime":"0","summary":"Regenxbio to join Baird, Morgan Stanley healthcare investor conferencesRegenxbio will attend the Baird 2026 Global Healthcare Conference in New York on Sept. 15, with a fireside chat at 8:30 a.m. ET.I","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDLb3qXKc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0912757837.SGD","LU2357305700.SGD","LU2271345857.HKD","LU1064131342.USD","LU2264538146.SGD","LU0210528500.USD","LU1720051108.HKD","RGNX","LU0795875086.SGD","LU2028103732.USD","LU1791710582.SGD","LU1244550221.USD","LU1244550494.USD","LU0106831901.USD","LU1668664300.SGD","BK4534","LU0234570918.USD","BK4585","LU0557290698.USD","BK4505","LU0320765646.SGD","LU1074936037.SGD","KBWB","LU1791710400.SGD","IE00B775SV38.USD","BK4127","LU1162221912.USD","LU1548497426.USD","BK4581","BK4563","LU2089284900.SGD","BK4139","LU0158827948.USD","LU0106261372.USD","BK4504","LU1989772923.USD","LU2133065610.SGD","LU1732800096.USD","BK4516","LU0882574139.USD","LU0158827781.USD","LU2487616109.SGD","LU0314104364.USD","MS","LU2347655156.SGD","IE00BKVL7J92.USD","LU1363072403.SGD","IAI","LU0098860793.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662622400","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2662622400","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662622400?lang=en_us&edition=fundamental","pubTime":"2026-08-28 19:15","pubTimestamp":1787915736,"startTime":"0","endTime":"0","summary":"Elastic  shares were up more than 20% pre-bell Friday after the company reported higher fiscal Q1 non-GAAP earnings and revenue.Solstice Advanced Materials  stock was 16% higher a day after the company said that it and Element Solutions  mutually agreed to terminate their previously announced merger agreement, with neither party required to pay a termination fee.Gap  shares were up more than 13% after the company raised its fiscal 2026 adjusted earnings guidance.Affirm  stock was over 12% higher after the company reported overnight a rise in fiscal Q4 earnings and sales in addition to issuing an upbeat fiscal Q1 sales outlook.Regenxbio  shares were up more than 7% after a 0.1% decline in the prior session.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4227","BK4139","LU0757428866.USD","BK4535","LU2098885051.SGD","BK4505","BK7022","LU2125909759.SGD","LU0054578231.USD","GAP","PSCM","SOLS","AFRM","BK4109","LU1303367103.USD","LU1861220207.SGD","LU1815336091.USD","BK4585","RGNX","LU1923622291.USD","BK4094","GAP.AU","BK4548","LU2360107671.USD","ESTC","LU2125909916.SGD","ESI","IE00BFMHRM44.USD","AFRU","LATR","BK4563","BK4106","BK4608","LU1861217088.USD","BK4613","BK4588","BK4023"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.regenxbio.com","stockEarnings":[{"period":"1week","weight":0.0193},{"period":"1month","weight":-0.0785},{"period":"3month","weight":-0.2745},{"period":"6month","weight":-0.1769},{"period":"1year","weight":-0.4146},{"period":"ytd","weight":-0.4861}],"compareEarnings":[{"period":"1week","weight":-0.0115},{"period":"1month","weight":0.0097},{"period":"3month","weight":0.029},{"period":"6month","weight":0.0855},{"period":"1year","weight":0.1456},{"period":"ytd","weight":0.1278}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the United States. Its gene therapy product candidates are based on NAV Technology Platform, a proprietary adeno-associated virus gene delivery platform. The company's products in pipeline includes ABBV-RGX-314 for the treatment of wet age-related macular degeneration, diabetic retinopathy, and other chronic retinal diseases; and RGX-202, which is in Phase I/II clinical trial for the treatment of Duchenne muscular dystrophy. It also develops RGX-121 for the treatment of mucopolysaccharidosis type II that is in Phase III clinical trial; RGX-111 for treating mucopolysaccharidosis type I; RGX-181 for the treatment of late infantile neuronal ceroid lipofuscinosis type II; and RGX-381 to treat the ocular manifestations of CLN2 disease. In addition, the company licenses its NAV Technology Platform to other biotechnology and pharmaceutical companies. Further, it has a collaboration and license agreement with AbbVie Global Enterprises Ltd. to develop ABBV-RGX-314 outside the United States. REGENXBIO Inc. was incorporated in 2008 and is headquartered in Rockville, Maryland.","yearOnYearQuotes":[{"month":1,"riseRate":0.363636,"avgChangeRate":-0.091067},{"month":2,"riseRate":0.272727,"avgChangeRate":0.000501},{"month":3,"riseRate":0.545455,"avgChangeRate":0.007203},{"month":4,"riseRate":0.636364,"avgChangeRate":0.038941},{"month":5,"riseRate":0.272727,"avgChangeRate":-0.040299},{"month":6,"riseRate":0.636364,"avgChangeRate":0.107793},{"month":7,"riseRate":0.363636,"avgChangeRate":-0.01896},{"month":8,"riseRate":0.363636,"avgChangeRate":0.01424},{"month":9,"riseRate":0.545455,"avgChangeRate":0.045975},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.057118},{"month":11,"riseRate":0.727273,"avgChangeRate":0.164969},{"month":12,"riseRate":0.363636,"avgChangeRate":-0.05132}],"exchange":"NASDAQ","name":"Regenxbio","nameEN":"Regenxbio"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Regenxbio(RGNX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Regenxbio(RGNX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Regenxbio,RGNX,Regenxbio股票,Regenxbio股票老虎,Regenxbio股票老虎国际,Regenxbio行情,Regenxbio股票行情,Regenxbio股价,Regenxbio股市,Regenxbio股票价格,Regenxbio股票交易,Regenxbio股票购买,Regenxbio股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Regenxbio(RGNX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Regenxbio(RGNX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction